Cheryl Reicin
Cheryl Reicin is a partner and international chair of life sciences at Mintz LLP, known for her expertise in the pharmaceutical industry. She has recently been in the news discussing the uncertainties surrounding potential U.S. tariffs and pricing rules that could significantly impact drug manufacturers.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Canada | 1 | 5.00 | 0.06% | +0% | 38,005,238 | 23,288 | $1,700,000 | 1,042$ |
| Totals | 1 | 38,005,238 | 23,288 | $1,700,000 | 1,042$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Canada:
Cheryl Reicin, partner and international chair of life sciences at Mintz LLP, expressed that her clients are not making any decisions yet due to uncertainty.
5